Cargando…
There is no place (yet) for routine administration of sildenafil to patients with ARDS
Autores principales: | Cornet, Alexander D., Juffermans, Nicole P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864901/ http://dx.doi.org/10.1007/s00134-010-1866-9 |
Ejemplares similares
-
Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS
por: Cornet, Alexander D., et al.
Publicado: (2010) -
Use of sildenafil in patients with severe COVID-19 pneumonitis
por: McFadyen, Charles, et al.
Publicado: (2022) -
Tuberculosis complicated by ARDS
por: Arevalo-Lorido, J. C., et al.
Publicado: (2001) -
Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021) -
Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)